Cassava Sciences Inc vs Invesco S&P 500 Momentum ETF — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Invesco S&P 500 Momentum ETF trades at $145.01. The key difference: Invesco S&P 500 Momentum ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SPMO | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $4.64 | $161.66 |
52-Week Low | $1.09 | $107.84 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPMO trades at $145.12, down 5.06% today amid neutral technical signals. The ETF maintains bullish moving averages but faces resistance near $150. Recent news highlights strong momentum performance with 7.5% gains in June 2026 (ETF Trends, 2026-07-01), though concentrated tech exposure introduces volatility. A $0.25 dividend is scheduled for June 2026.
Outlook remains constructive given AI-driven momentum tailwinds, but high concentration in tech sectors poses risks during market rotations. Analyst sentiment is mixed with neutral ratings outweighing buys. Key support sits at $143, with upside potential if momentum resumes above $152 resistance.
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →